Emerging role of exosomes as biomarkers in cancer treatment and diagnosis

NA Hanjani, N Esmaelizad, S Zanganeh… - Critical reviews in …, 2022 - Elsevier
Cancer is a leading cause of death worldwide and cancer incidence and mortality are
rapidly growing. These massive amounts of cancer patients require rapid diagnosis and …

Current status and prospects of targeted therapy for osteosarcoma

Z Hu, S Wen, Z Huo, Q Wang, J Zhao, Z Wang, Y Chen… - Cells, 2022 - mdpi.com
Osteosarcoma (OS) is a highly malignant tumor occurring in bone tissue with a high
propensity to metastasize, and its underlying mechanisms remain largely elusive. The OS …

A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA

M Yang, H Zheng, K Xu, Q Yuan, Y Aihaiti… - Frontiers in …, 2022 - frontiersin.org
Objective Osteosarcoma (OS) is a common bone malignancy with poor prognosis. We
aimed to investigate the relationship between cuproptosis-related lncRNAs (CRLncs) and …

Injectable self-healing cellulose hydrogel based on host-guest interactions and acylhydrazone bonds for sustained cancer therapy

X Jiang, F Zeng, X Yang, C Jian, L Zhang, A Yu, A Lu - Acta Biomaterialia, 2022 - Elsevier
Tumor local chemotherapy employing injectable hydrogel reservoirs is a promising platform
to achieve precise drug administration. However, balanced injectability, pH-responsiveness …

MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression

J Lin, A Xu, J Jin, M Zhang, J Lou, C Qian, J Zhu… - …, 2022 - Taylor & Francis
The poor progress of immunotherapy on osteosarcoma patients requires deeper delineation
of immune tolerance mechanisms in the osteosarcoma microenvironment and a new …

Targeted therapy for osteosarcoma: a review

S Li, H Zhang, J Liu, G Shang - Journal of cancer research and clinical …, 2023 - Springer
Background Osteosarcoma is a common primary malignant tumour of the bone that usually
occurs in children and adolescents. It is characterised by difficult treatment, recurrence and …

Single-cell transcriptomics reveals the complexity of the tumor microenvironment of treatment-naive osteosarcoma

Y Liu, W Feng, Y Dai, M Bao, Z Yuan, M He… - Frontiers in …, 2021 - frontiersin.org
Osteosarcoma (OS), which occurs most commonly in adolescents, is associated with a high
degree of malignancy and poor prognosis. In order to develop an accurate treatment for OS …

Tumor-associated macrophages induce inflammation and drug resistance in a mechanically tunable engineered model of osteosarcoma

LK Chim, IL Williams, CJ Bashor, AG Mikos - Biomaterials, 2023 - Elsevier
The tumor microenvironment is a complex and dynamic ecosystem composed of various
physical cues and biochemical signals that facilitate cancer progression, and tumor …

TP53 in biology and treatment of osteosarcoma

KJ Synoradzki, E Bartnik, AM Czarnecka… - Cancers, 2021 - mdpi.com
Simple Summary Treatment of osteosarcoma, apart from chemotherapy modifications, has
not changed for approximately 30 years. Similarly, as in other tumors, mutations in the TP53 …

Anti-cancer properties of quercetin in osteosarcoma

P Maleki Dana, F Sadoughi, Z Asemi, B Yousefi - Cancer cell international, 2021 - Springer
Osteosarcoma is a primary bone tumor. Although it is a rare disease in general, it is the most
common primary bone tumor among children. Despite the significant advances made in the …